newsfilter
← Latest News
ACCESS Newswire·

Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval

The number of oral weight-loss / diabetes drug treatments is expanding, increasing demand for the reduction of side effectsKELOWNA, BC / ACCESS Newswire / April 7, 2026 / Lexaria Bioscience Corp. , (the